Successful outcome of Scedosporium apiospermum disseminated infection treated with voriconazole in a patient receiving corticosteroid therapy.
about
Tracking the emerging human pathogen Pseudallescheria boydii by using highly specific monoclonal antibodiesInfections caused by Scedosporium spp.Scedosporium apiospermum: changing clinical spectrum of a therapy-refractory opportunist*In vitro activities of four novel triazoles against Scedosporium sppScedosporium apiospermum soft tissue infection successfully treated with voriconazole: potential pitfalls in the transition from intravenous to oral therapy.Review of the safety and efficacy of voriconazole.Activity of posaconazole against Pseudallescheria boydii: in vitro and in vivo assays.Antifungal pharmacotherapy for invasive mould infections.Voriconazole: a new triazole antifungal agent.Voriconazole in the management of nosocomial invasive fungal infections.Scedosporium prolificans osteomyelitis in an immunocompetent child treated with voriconazole and caspofungin, as well as locally applied polyhexamethylene biguanideScedosporium species infections and treatments.New and emerging antifungal agents: impact on respiratory infections.Voriconazole, a novel wide-spectrum triazole: oral pharmacokinetics and safetyVoriconazole: therapeutic review of a new azole antifungal.Emerging azole antifungals.Voriconazole: review of a broad spectrum triazole antifungal agent.Pseudallescheriasis in the 21st century.Voriconazole in the treatment of fungal osteomyelitis of the orbit in the immunocompromised host.Cavitary pulmonary disease.Voriconazole: a broad-spectrum triazole for the treatment of invasive fungal infections.Solid lipid nanoparticles for antifungal drugs delivery for topical applications.Correlation between in vitro susceptibility of Scedosporium apiospermum to voriconazole and in vivo outcome of scedosporiosis in guinea pigs.Voriconazole: a broad spectrum triazole for the treatment of serious and invasive fungal infections.Scedosporium apiospermum as a rare cause of central skull base osteomyelitis.Efficacy of voriconazole in treatment of systemic scedosporiosis in neutropenic miceFungal septal abscess complicating maxillary sinus fungus balls in an immunocompetent host.[Voriconazole - applications and perspectives]Voriconazole treatment for less-common, emerging, or refractory fungal infections.Voriconazole in fungal keratitis caused by Scedosporium apiospermum.Chronic pulmonary scedosporiosis simulating aspergillosis.Fungal Contaminants in Drinking Water Regulation? A Tale of Ecology, Exposure, Purification and Clinical Relevance.Disseminated Scedosporium apiospermum infection in a previously healthy woman with HELLP syndrome.New agents for the treatment of systemic fungal infections--current status.Pacemaker endocarditis with pulmonary cavitary lesion due to Scedosporium prolificans.Opportunistic mycelial fungal infections in organ transplant recipients: emerging importance of non-Aspergillus mycelial fungi.Recent Advances in the Treatment of Scedosporiosis and Fusariosis.
P2860
Q24644571-4B15E2E9-5547-4AD8-936F-64BDB0A4C992Q24657691-7A719ABD-0518-4FF2-92A6-E3A992F320B2Q28315344-21FF5F4E-698C-46DB-9057-2CFC2C80DE57Q28366842-DFE5D273-14F5-4311-B75A-E80F40F9C890Q33824506-1D3A8362-730F-4B77-AD69-23A2A8F2ED37Q34544679-E475D0EB-8FB7-413B-A583-92FF0932345FQ34882440-72162EFC-2B10-4D78-809C-C30F565E8196Q35058091-B8551F9F-3FAA-4844-90F6-24057DE30BC4Q35069136-114F2A6C-8C3A-4BBA-B8B1-BBBF76857EC8Q35166823-F472BC3E-166B-49D5-B3EF-8BF79B441755Q35194598-2381E6EA-117A-457D-A17C-297F621779CFQ35622016-D258FC40-69FC-4B42-B1F2-33F6909FAEB1Q35627629-3FCF7D30-6488-45BC-B416-341315A4224CQ35825582-4D188CC8-57E9-4276-8650-36B8E1D9BF29Q35917452-9027A186-1F70-45DF-9969-DFF44874BB34Q36066009-360F7E9B-300B-4A36-BC5D-F866BA6E5CDAQ36164008-A9544CEB-12CF-433A-B625-0B217397E711Q36278064-2017CD55-8EA6-49DA-9A1A-8DFD27057C32Q36342105-2557E27F-BFA5-4023-92C6-0C67C97F069FQ36538804-1567B95D-1AEB-42D3-BDB1-F6EE7B148C3FQ37810091-65922CB4-32EC-484D-8A50-1CB4BF794CB7Q38943050-37FCF0C1-4EE3-4D4C-8C4A-9AAE704AA275Q40165489-3E1C6D21-3C99-4148-A094-23508B262EA2Q40189236-B5C101C8-4EAB-4A7C-B0A0-D06E5B2080DCQ40279699-FA624909-9D91-44AF-A5AD-5542770FA7E3Q40345252-2464E396-B8FA-4DF4-A4D0-7A17069CD121Q40864637-E0A42035-4CC0-44C9-9082-C6BCF0AFF02EQ44400539-E34E32A1-49D3-48AB-B975-21836D2C04F3Q44417870-ADD5EA88-33EC-41AE-A24C-7189691C588DQ44750476-4EBBF8B0-3356-4615-B117-B26618A0AA69Q45280508-EBDFA02A-11D0-46F0-A8DC-5CA00B30BB30Q45969597-74B220E4-16FE-4DC3-8946-97AAA8E09F17Q46345785-92AD0DE0-50A1-4F05-A85A-7BE80964DB7DQ46576615-BD0CFF7B-5242-48B6-8214-B789D7260EE8Q51076348-4B962705-E1E2-4F5B-978C-82648D6119EDQ51190403-88D0261E-FEC4-4DD9-8FAC-DDB6906C2E2BQ55453637-BF1048D5-A21A-4D33-8B55-7EB3199033A9
P2860
Successful outcome of Scedosporium apiospermum disseminated infection treated with voriconazole in a patient receiving corticosteroid therapy.
description
2000 nî lūn-bûn
@nan
2000 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Successful outcome of Scedospo ...... eiving corticosteroid therapy.
@ast
Successful outcome of Scedospo ...... eiving corticosteroid therapy.
@en
Successful outcome of Scedospo ...... eiving corticosteroid therapy.
@nl
type
label
Successful outcome of Scedospo ...... eiving corticosteroid therapy.
@ast
Successful outcome of Scedospo ...... eiving corticosteroid therapy.
@en
Successful outcome of Scedospo ...... eiving corticosteroid therapy.
@nl
prefLabel
Successful outcome of Scedospo ...... eiving corticosteroid therapy.
@ast
Successful outcome of Scedospo ...... eiving corticosteroid therapy.
@en
Successful outcome of Scedospo ...... eiving corticosteroid therapy.
@nl
P2093
P2860
P356
P1476
Successful outcome of Scedospo ...... eiving corticosteroid therapy.
@en
P2093
Martín Rabadán P
Rodríguez-Creixéms M
P2860
P304
P356
10.1086/317496
P407
P577
2000-12-01T00:00:00Z